You are here

Article Text

Article menu
Download PDFPDF
Community child health, public health, and epidemiology
Bisphosphonate treatment of bone disease
  1. N J Shaw1,
  2. N J Bishop2
  1. 1Department of Endocrinology, Birmingham Children’s Hospital, UK
  2. 2Academic Unit of Child Health, Sheffield Children’s Hospital, University of Sheffield, UK
  1. Correspondence to:
    Dr N J Shaw
    Dept of Endocrinology, Birmingham Children’s Hospital, Steelhouse Lane, Birmingham B4 6NH, UK; nick.shawbch.nhs.uk

Abstract

In 1997 a review article on bisphosphonates in this journal identified 24 published articles relating to children at that time.1 Since then there has been a considerable increase in their use in clinical paediatric practice and research with there being nearly a further one hundred articles published at the time of writing.

  • bisphosphonates
  • treatment

https://doi.org/10.1136/adc.2003.036590

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests: NJS and NJB have received funding from Novartis and the Arthritism & Rheumatism Council for studies of bisphosphonates in osteogenesis imperfecta. NJB has acted as an independent consultant for Proctor & Gamble.